Programme

Inauguration

Dr. Ángel Carracedo. Director of Genomic medicine foundation
Dra. Angélica Figueroa. Principal Investigator of INIBIC

Sesion I – innovation: drug discovery and development in cancer

CHAIR:

Dra. Mabel Loza. Professor of pharmacology at USC, scientific director and founder in Kaertor Foundation

→ 09:30-09:50 h.

Dra. Laura Soucek. Principal Investigator of VHIO´s Models of Cancer Therapies Group. ICREA Research Professor. Co-founder & CEO at PEPTOMYC S.L

THE JOURNEY OF A FIRST-IN-CLASS MYC INHIBITOR FROM BENCH TO CLINICAL TRIAL

→ 10:00-10:20 h.

Dr. Salvador A. Benitah. ICREA Senior Group Leader at IRB, Co-founder & CSO at ONA Therapeutics

EPIGENETIC CONSEQUENCES OF OUR (FATTY) DIET IN METASTASIS: ROLE OF SCHWANN CELLS

→ 10:30-10:50 h.

Dr. Héctor G. Palmer. Principal Investigator of VHIO´s Stem Cells and Cancer Group. Co-founder & CSO at Oniria Therapeutics

To be confirmed

→ 11:00-11:20 h.

Dra. Angélica Figueroa. Principal Investigator of INIBIC. Epithelial Plasticity and Metastasis Group

TARGETING PROTEIN DEGRADATION AGAINST CANCER

BREAK AND POSTER SESSION

Sesion II – CANCER RESEARCH WITH CLINICAL IMPACT

CHAIR:

Dr. Xose Bustelo. Full Professor at CSIC. Cancer Research Center-Salamanca University

→ 12:00-12:20 h.

Dr. Manuel Valiente. Principal investigator Brain Metastasis Group at CNIO

STRATEGIES TO CHALLENGE BRAIN METASTASIS LETHALITY IN MICE AND HUMAN

→ 12:30-12:50 h.

Dr. Javier de las Rivas. Principal Investigator at CSIC, Bioinformatics and Functional Genomics. Cancer Research Center Salamanca University

DISCOVERY OF GENE MARKERS ASSOCIATED WITH SURVIVAL AND RISK IN COLORECTAL CANCER (CRC) AND BREAST CANCER (BRCC)

→ 13:00-13:20 h.

Dr. Víctor Moreno. Director Clinical Research Phase 1 Trials Unit. START Madrid-FJD, Hospital Fundación Jiménez Díaz

CELLULAR THERAPY FOR SOLID TUMOURS

→ 13:30-14:00 h.

Dra. Sonia Zumalave. PhD candidate at Mobile Genomes Lab (CiMUS, University of Santiago de Compostela).

THE IMPACT OF SOMATIC RETROTRANSPOSON ACTIVITY IN THE ORIGIN AND DEVELOPMENT OF HUMAN CANCER

BREAK

Sesion IV – Young Researchers

Selected Short talks from received communications

CHAIR:

Dra. Esperanza Cerdán. Full Professor at Universidade da Coruña (UDC) / Advanced Scientific Research Center (CICA)

Oral presentation 10 min

INTRA-TUMOR COMBINATION THERAPY WITH POLY(I:C) AND RESIQUIMOD FREE OR LOADED IN POLYMERIC NANOCAPSULES SYNERGISTICALLY TRIGGERS TUMOR-ASSOCIATED MACROPHAGES FOR EFFECTIVE ANTI-TUMORAL IMMUNITY
TORRES ANDÓN, FERNANDO(1);ANFRAY, CLEMENT(2);UMMARINO, ALDO(2);MAININI, FRANCESCO(2);ERRENI, MARCO(2);ANSELMO, ACHILLE(2);GANDOY, SARA(1);EXPÓSITO, FRAN(3);CALVO, ALFONSO(3);MARTENS, MARVIN(4);BRAVO, SUSANA(5);DACOBA, TAMARA(1);CRECENTE, JOSE(1);MANTOVANI, ALBERTO(2);ALONSO, MARÍA JOSÉ(1);ALLAVENA, PAOLA(2)
(1)USC;(2)IRCCS;(3)UNAV;(4)UM;(5)IDIS

A2AB ADENOSINE RECEPTOR ANTAGONISTS RESCUE LYMPHOCYTE ACTIVITY IN ADENOSINE-PRODUCING PATIENT-DERIVED CANCER MODELS
PRIETO DÍAZ, RUBÉN(1);FOJO CARBALLO, HUGO(1);AZUAJE GUERRERO, JHONNY(1);MAJELLARO, MARIA(1);GARCÍA MERA, XERARDO(2);LOZA GARCÍA, MARÍA ISABEL(3);BREA FLORIANI, JOSE(3);TAY, APPLE(4);GUTIÉRREZ DE TERÁN, HUGO(5);LUNDQVIST, ANDREAS(4);SOTELO PÉREZ, EDDY(1)
(1)CENTER FOR RESEARCH IN BIOLOGICAL CHEMISTRY AND MOLECULAR MATERIALS (CIQUS), UNIVERSITY OF SANTIAGO DE COMPOSTELA;(2)ORGANIC CHEMISTRY DEPARTMENT, PHARMACY FACULTY, UNIVERSITY OF SANTIAGO DE COMPOSTELA;(3)CENTER FOR RESEARCH IN METABOLIC DISEASES (CIMUS), UNIVERSITY OF SANTIAGO DE COMPOSTELA;(4)DEPARTMENT OF ONCOLOGY-PATHOLOGY, KAROLINSKA INSTITUTE, STOCKHOLM;(5)DEPARTMENT OF CELL AND MOLECULAR BIOLOGY, UPPSALA UNIVERSITY

DISSECTING THE RELATIVE CONTRIBUTION OF EXTRACELLULAR VESICLES TO PARACRINE SENESCENCE DURING CANCER CHEMOTHERAPY
ESTÉVEZ-SOUTO, VALENTÍN(1);DA SILVA-ÁLVAREZ, SABELA(1);PEDROSA, PABLO(1);PICALLOS-RABINA, PILAR(1);ANTELO-IGLESIAS, LUCÍA(1);LADO-FERNÁNDEZ, PATRICIA(1);NÚÑEZ-QUINTELA, VÍCTOR(1);GONZÁLEZ-BARCIA, MIGUEL(1);COLLADO, MANUEL(1)
 (1)HEALTH RESEARCH INSTITUTE OF SANTIAGO DE COMPOSTELA (IDIS)

STUDY OF FERROPTOSIS TRANSMISSION BY SMALL EXTRACELLULAR VESICLES IN EPITHELIAL OVARIAN CANCER CELLS
ALARCÓN-VELEIRO, CARMEN(1);MATO-BASALO, ROCÍO(1);LUCIO-GALLEGO, SERGIO(1);QUINDÓS-VARELA, MARÍA(2);AL-QATARNEH, THAMER(3);VIZOSO, ÁNGEL(3);ARUFE, MARÍA C(1);FAFIÁN-LABORA, JUAN(1)
(1)UDC-INIBIC-CICA;(2)INIBIC-CHUAC;(3)UDC-CICA

RED BLOOD CELLS PROTEOMIC PROFILE CHANGES IN BREAST CANCER PATIENTS
PEREIRA-VEIGA, THAIS(1);YÁÑEZ GÓMEZ, CELSO(1);BRAVO, SUSANA(2);GÓMEZ-TATO, ANTONIO(3);ABUÍN, CARMEN(4);VARELA, VANESA(5);CUEVA, JUAN(5);PALACIOS, PATRICIA(5);DÁVILA-IBÁÑEZ, ANA B.(5);PIÑEIRO-CID, ROBERTO(1);VILAR, ANA(1);LÓPEZ, RAFAEL(1);COSTA, CLOTILDE(5)
 (1)ROCHE-CHUS JOINT UNIT, TRANSLATIONAL MEDICAL ONCOLOGY GROUP, ONCOMET;(2)PROTEOMIC UNIT, INSTITUTO DE INVESTIGACIONES SANITARIAS-IDIS,;(3)SCHOOL OF MATHEMATICS, UNIVERSITY OF SANTIAGO DE COMPOSTELA (CAMPUS VIDA);(4)ROCHE-CHUS JOINT UNIT, TRANSLATIONAL MEDICAL ONCOLOGY GROUP, ONCOMET,;(5)DEPARTMENT OF GYNECOLOGY, UNIVERSITY HOSPITAL OF SANTIAGO DE COMPOSTELA (SERGAS), SPAIN

Oral presentation 5 min

HMGB1 AND HMGB2 NON-CODING RNA INTERACTOME IN PEO1 OVARIAN CANCER CELL LINE WITH POTENTIAL CLINICAL RELEVANCE
SALAMINI MONTEMURRI, MARTÍN(1);LORENZO CATOIRA, LIDIA(1);VIZOSO VÁZQUEZ, ÁNGEL(1);BARREIRO ALONSO, AIDA(1);LAMAS MACEIRAS, MÓNICA(1);CERDÁN VILLANUEVA, MARÍA ESPERANZA(1)
 (1)EXPRELA, CENTRO DE INVESTIGACIONES CIENTÍFICAS AVANZADAS – UNIVERSIDAD DE A CORUÑA, SPAIN & INIBIC (INSTITUTO DE INVESTIGACIÓN BIOMÉDICA DE A CORUÑA), SPAIN

CELLULAR REPROGRAMMING AS A TOOL FOR THE STUDY OF CANCER
PEDROSA LADO, PABLO(1);NÚÑEZ QUINTELA, VÍCTOR(1);DA SILVA ÁLVAREZ, SABELA(1);PICALLOS RABINA, PILAR(1);ESTÉVEZ SOUTO, VALENTÍN(1);LADO FERNÁNDEZ, PATRICIA(1);ANTELO IGLESIAS, LUCÍA(1);COLLADO RODRÍGUEZ, MANUEL(1)
(1)IDIS

CTCS EXPRESSION ANALYSIS PREDICTS RESPONSE TO POLYTHERAPY IN LUMINAL METASTATIC BREAST CANCER PATIENTS
GLEZ CONDE, MIRIAM(1);YÁÑEZ GOMEZ, CELSO(1);ABUIN, CARMEN(1);CUEVA, JUAN(2);PALACIOS, PATRICIA(2);LÓPEZ-LÓPEZ, RAFAEL(3);COSTA-NOGUEIRA, CLOTILDE(1)
(1)UNIDAD MIXTA ROCHE CHUS;(2)DEPARTAMENTO ONCOLOGICO CHUS;(3)DEPARTAMENTO ONCOLÓGICO CHUS

FUNCTIONAL AND BIOPHYSICAL CHARACTERIZATION OF HMGB1-BGAS LNCRNA INTERACTION IN THE DIAGNOSIS OF OVARIAN CANCER
REY-SOUTO, CORA(1);AL-QATARNEH, THAMER(1);FRANCO-GACIO, ANAHIR(1);SALAMINI- MONTEMURRI, MARTÍN(1);LOMBA-RIEGO, LUCÍA(1);LAMAS-MACEIRAS, MÓNICA(1);CERDÁN, MARÍA ESPERANZA(1);VIZOSO-VÁZQUEZ, ÁNGEL(1)
(1)UNIVERSIDADE DA CORUÑA, EXPRELA GROUP, CENTRO DE INVESTIGACIÓNS CIENTÍFICAS AVANZADAS (CICA), RÚA AS CARBALLEIRAS, 15071, A CORUÑA, SPAIN. DEPARTAMENTO DE BIOLOXÍA, FACULTADE DE CIENCIAS, RÚA DA FRAGA, 15071, A CORUÑA, SPAIN.

Award and closure

Dra. Angélica Figueroa. Principal Investigator of INIBIC
Dra. Esperanza Cerdán. Full Professor at Universidade da Coruña (UDC) / Advanced Scientific Research Center (CICA)